Crown Bioscience Inc (6554):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Crown Bioscience Inc (6554) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7858
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Crown Bioscience Inc (Crown Bioscience) is a drug discovery company that provides drug discovery and development services. The company offers antibodies, proteins, cell lines, tumor samples, in vivo and in vitro research reagents. It offers services such as preclinical research services, oncology services, and metabolic disease services, among others. Crown Bioscience provides its preclinical research services in areas of oncology and metabolic disease. The company’s oncology services comprise human surrogate trials, oncology databases, ex vivo services, in vitro services, in vivo services, translational research, preclinical formulations, and drug discovery services. Its metabolic disease services include CVMD databases, and ex vivo services. The company has its operations in the US, China, the UK, and Taiwan. Crown Bioscience is headquartered in Taipei, Taiwan.

Crown Bioscience Inc (6554) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Crown Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Crown Bioscience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Crown Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Crown Bioscience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Crown Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Crown Bioscience Inc, Medical Equipment, Deal Details 10
Partnerships 10
Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 10
Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 11
Equity Offering 12
Crown Bioscience Raises USD20.8 Million in Public Offering of Shares 12
Acquisition 13
JSR Acquires Crown Bioscience for USD399.7 Million 13
Crown Bioscience Acquires PreClinOmics 15
Crown Bioscience Inc – Key Competitors 16
Crown Bioscience Inc – Key Employees 17
Crown Bioscience Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
Jul 13, 2017: Crown Bioscience Expands its Life Science Portfolio 19
Jan 26, 2017: CrownBio Announces Expansion of Life Science Division 20
Financial Announcements 21
Aug 10, 2017: Crown Bioscience Announces Second Quarter Results 21
May 19, 2017: Crown Bioscience Announces Record Breaking Growth With First 2017 Quarter Results 22
Corporate Communications 23
Jun 06, 2018: Laurie Heilmann Named President of New CrownBio Global Life Science and Diagnostic Solutions Division 23
Nov 09, 2017: Crown Bioscience Announcing the 2017 Board of Directors Election Results Dr. Guoliang Yu re-elected as the Chairman 24
Sep 27, 2017: Crown Bioscience Names Laurie Heilmann Chief Business Officer; Executive Leader Brings Expertise in Global Strategy and Commercial Leadership to the Role 25
Aug 22, 2017: Crown Bioscience Names Dr. Leon Hall Vice President of Global Scientific Excellence 26
Aug 10, 2017: Crown Bioscience Appoints Dr. Yangzhou Wang as Sr. VP of Global Operations 27
Product News 28
Feb 27, 2018: Webinar to Reveal Data Supporting the Use of MuScreen for Preclinical Immunotherapeutic Development 28
Nov 23, 2017: Crown Bioscience and Data Sciences International (DSI) Partner to Advance Metabolic Disease Research Using an Implanted Telemetry Device for Long-Term Blood Glucose Monitoring 29
Jun 01, 2017: Crown Bioscience Showcases Dramatic Proficiency in PDX Models and Emerging Expertise in Immune-Oncology 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Crown Bioscience Inc, Medical Equipment, Key Facts, 2017 2
Crown Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Crown Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Crown Bioscience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Crown Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Crown Bioscience Inc, Deals By Market, 2012 to YTD 2018 8
Crown Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 10
Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 11
Crown Bioscience Raises USD20.8 Million in Public Offering of Shares 12
JSR Acquires Crown Bioscience for USD399.7 Million 13
Crown Bioscience Acquires PreClinOmics 15
Crown Bioscience Inc, Key Competitors 16
Crown Bioscience Inc, Key Employees 17
Crown Bioscience Inc, Other Locations 18
Crown Bioscience Inc, Subsidiaries 18

List of Figures
Crown Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Crown Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Crown Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Crown Bioscience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Crown Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Crown Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Crown Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Crown Bioscience Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Crown Bioscience Inc (6554):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NEC Networks & System Integration Corp (1973):企業の財務・戦略的SWOT分析
    NEC Networks & System Integration Corp (1973) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Da Afghanistan Breshna Sherkat:企業の戦略的SWOT分析
    Da Afghanistan Breshna Sherkat - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Kadaster:企業の戦略的SWOT分析
    Kadaster - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Axalta Coating Systems Ltd.:戦略・SWOT・企業財務分析
    Axalta Coating Systems Ltd. - Strategy, SWOT and Corporate Finance Report Summary Axalta Coating Systems Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • African Phoenix Investments Limited:企業の戦略・SWOT・財務情報
    African Phoenix Investments Limited - Strategy, SWOT and Corporate Finance Report Summary African Phoenix Investments Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • CaixaBank SA:企業の戦略・SWOT・財務情報
    CaixaBank SA - Strategy, SWOT and Corporate Finance Report Summary CaixaBank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Global Partners LP (GLP)-石油・ガス分野:企業M&A・提携分析
    Summary Global Partners LP (Global Partners) is a midstream logistics and marketing company. It carries out purchasing, selling and logistics of transporting domestic and Canadian crude oil and other products by rail across its virtual pipeline from the mid-continent region of the US and Canada to t …
  • Blue Label Telecoms Ltd (BLU):企業の財務・戦略的SWOT分析
    Blue Label Telecoms Ltd (BLU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Pioneer Corporation (6773):企業の財務・戦略的SWOT分析
    Pioneer Corporation (6773) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Dow Inc (DOW):企業の財務・戦略的SWOT分析
    Dow Inc (DOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • University of South Florida-製薬・医療分野:企業M&A・提携分析
    Summary University of South Florida (USF) is an educational university that offers undergraduate, graduate, specialist and doctoral level degrees. The university offers degrees in various fields including accounting, advertising, Africana studies, American studies, anthropology, applied science, mar …
  • DAIS Corp (DLYT):企業の財務・戦略的SWOT分析
    Summary Dais Corps (Dais) is an alternative energy company. It provides industry changing and nano technology based applications. The company's products include ultra capacitors, clean water systems, heating and cooling equipment, among others. It also provides NanoAir, NanoCap, ConsERV and NanoClea …
  • Benefitfocus Inc (BNFT):企業の財務・戦略的SWOT分析
    Summary Benefitfocus Inc (Benefitfocus) is a technology service provider that offers cloud- based software solutions. The company provides cloud-based benefits management platform for shopping, enrolling, managing and exchanging benefit information for employers, insurance carriers, brokers, and con …
  • Zimmer Biomet Holdings Inc (ZBH):企業の財務・戦略的SWOT分析
    Zimmer Biomet Holdings Inc (ZBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Kuwait Energy Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Kuwait Energy Plc (Kuwait Energy) is an independent oil and gas company that carries out exploration, appraisal, development and production of hydrocarbons. The company operates wide range of oil and gas assets in Middle East and North Africa (MENA) region. It has assets across Egypt, Yemen, …
  • Hoya Corp (7741):医療機器:M&Aディール及び事業提携情報
    Summary Hoya Corp (Hoya) is a global med-tech company that manufactures and sells precision devices and instruments built on its advanced optics technologies. Principal products include eyeglass and contact lenses, medical endoscopes, laparoscopic surgical instruments, intraocular lenses, orthopedic …
  • Banca IFIS SpA:企業の戦略・SWOT・財務情報
    Banca IFIS SpA - Strategy, SWOT and Corporate Finance Report Summary Banca IFIS SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Tech Mahindra Limited (TECHM):企業の財務・戦略的SWOT分析
    Tech Mahindra Limited (TECHM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Intech Biopharm Ltd (6461):製薬・医療:M&Aディール及び事業提携情報
    Summary Intech Biopharm Ltd (Intech Biopharm) is a drug developing company that develops drugs for obstructive airway diseases. The company provides marketed products such as single ingredient generics such as Synvent, and Duasma, developed for asthma; and multi-ingredient generic, Synflutide, for a …
  • LIG Nex1 Co., Ltd.:企業の戦略・SWOT・財務情報
    LIG Nex1 Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary LIG Nex1 Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆